Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended March 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-27945

 

ASCENDANT SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   75-2900905

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

16250 Dallas Parkway, Suite 102, Dallas, Texas   75248
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 972-250-0945

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x

 

At May 14, 2004, there were approximately 21,665,900 shares of Ascendant Solutions, Inc. common stock outstanding.

 



Table of Contents

ASCENDANT SOLUTIONS, INC.

 

FORM 10-Q

 

For the Quarterly Period Ended March 31, 2004

 

PART I.

 

CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

ITEM 1.    CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS    1
ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS    11
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK    16
ITEM 4.    CONTROLS AND PROCEDURES    16
PART II.
OTHER INFORMATION
ITEM 1.    LEGAL PROCEEDINGS    17
ITEM 2.    CHANGES IN SECURITIES AND USE OF PROCEEDS    17
ITEM 3.    DEFAULTS UPON SENIOR SECURITIES    18
ITEM 4.    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS    18
ITEM 5.    OTHER INFORMATION    18
ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K    19
SIGNATURE    20
CERTIFICATIONS     

 


Table of Contents

ASCENDANT SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(000’s omitted, except per share amounts)

 

     March 31,
2004


    December 31,
2003


 
     (Unaudited)        
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 2,281     $ 2,006  

Trade accounts receivable

     5,094       —    

Other receivables

     134       46  

Receivable from affiliates

     43       52  

Inventories

     2,281       —    

Prepaid expenses

     226       125  
    


 


Total current assets

     10,059       2,229  

Property and equipment, net

     573       17  

Deferred acquisition costs

     152       310  

Intangible assets

     370       —    

Investments in limited partnerships

     274       285  

Other assets

     17       —    
    


 


Total assets

   $ 11,445     $ 2,841  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 1,670     $ 60  

Accounts payable to affiliates

     3       1  

Accrued liabilities

     729       48  

Notes payable, current

     431       —    
    


 


Total current liabilities

     2,833       109  

Notes payable, long-term

     5,921       —    

Limited partnership interests

     248       209  

Commitments and contingencies

                

Stockholders’ equity:

                

Preferred stock, $0.0001 par value:

                

Authorized shares—7,500,000

                

Issued and outstanding—none

     —         —    

Common stock, $0.0001 par value:

                

Authorized shares—50,000,000

                

Issued and outstanding shares—21,665,900 at March 31, 2004 and December 31, 2003

     2       2  

Additional paid-in capital

     59,840       59,822  

Deferred compensation

     (38 )     (46 )

Accumulated deficit

     (57,361 )     (57,255 )
    


 


Total stockholders’ equity

     2,443       2,523  
    


 


Total liabilities and stockholders’ equity

   $ 11,445     $ 2,841  
    


 


 

See accompanying notes to the Condensed Consolidated Financial Statements.

 

1


Table of Contents

ASCENDANT SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(000’s omitted, except per share amounts)

(Unaudited)

 

    

Three Months Ended

March 31,


 
     2004

    2003

 

Revenue:

                

Real estate advisory revenues

   $ 470     $ 40  

Healthcare service revenues

     775       —    
    


 


       1,245       40  

Cost of healthcare service revenues

     507       —    
    


 


Gross profit

     738       40  
    


 


Operating expenses:

                

Selling, general and administrative expenses

     847       347  

Depreciation and amortization

     6       14  

Non-cash stock option compensation

     18       0  
    


 


Total operating expenses

     871       361  
    


 


Operating loss

     (133 )     (321 )

Investment income

     70       14  

Interest income (expense), net

     (3 )     10  

Limited partner interest in net (income) losses of partnerships

     (40 )     80  
    


 


Net loss

   $ (106 )   $ (217 )
    


 


Basic and diluted net loss per share

   $ (0.00 )   $ (0.01 )
    


 


Weighted average shares used in computing basic and diluted net loss per share

     21,665,900       21,230,900  
    


 


 

See accompanying notes to the Condensed Consolidated Financial Statements.

 

2


Table of Contents

ASCENDANT SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(000’s omitted)

(Unaudited)

 

     Three Months Ended
March 31,


 
     2004

    2003

 

Operating Activities

                

Net loss

   $ (106 )   $ (217 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

                

Depreciation and amortization

     6       14  

Deferred compensation amortization

     9       9  

Non-cash stock option compensation

     18       0  

Limited partner interest in net income (losses) of partnerships

     40       (80 )

Changes in operating assets and liabilities, net of effects from the purchase of the Park Assets:

                

Accounts receivable

     55       23  

Prepaid expense

     34       41  

Accounts payable

     477       58  

Accrued liabilities

     —         (6 )
    


 


Net cash provided by (used in) operating activities

   $ 533     $ (158 )
    


 


Investing Activities

                

Deferred acquisition costs

     (314 )     —    

Payment of liabilities in connection with the acquisition of the Park Assets

     (1,350 )     —    

Net cash acquired in connection with the acquisition of the Park Assets

     1,396       —    

Return of capital distributions

     11       10  

Purchases of property and equipment

     (1 )     (11 )
    


 


Net cash used in investing activities

     (258 )     (1 )
    


 


Financing Activities

                

Proceeds from sale of limited partnership interests

     —         128  
    


 


Net cash provided by financing activities

     —         128  
    


 


Net increase (decrease) in cash and cash equivalents

     275       (31 )

Cash and cash equivalents at beginning of period

     2,006       2,950  
    


 


Cash and cash equivalents at end of period

   $ 2,281     $ 2,919  
    


 


 

See accompanying notes to the Condensed Consolidated Financial Statements.

 

3


Table of Contents

ASCENDANT SOLUTIONS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Basis of Presentation

 

The unaudited condensed consolidated financial statements included herein reflect all adjustments, consisting only of normal recurring adjustments, which in the opinion of management are necessary to fairly state Ascendant Solutions, Inc.’s (“Ascendant Solutions” or the “Company”) consolidated financial position, consolidated results of operations and consolidated cash flows for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Form 10-K for the year ended December 31, 2003 as filed with the Securities and Exchange Commission. The consolidated results of operations for the period ended March 31, 2004 are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire fiscal year ending December 31, 2004. The December 31, 2003 consolidated balance sheet was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

 

2. Description of Business

 

Ascendant Solutions is a diversified financial services company seeking to invest in, or acquire, manufacturing, distribution or service companies. The Company also conducts various real estate activities, performing real estate advisory services for corporate clients, and, through an affiliate, purchases real estate assets as a principal.

 

2002 TO 2003 INVESTMENTS

 

Ampco Partners, Ltd.

 

During the second quarter of 2002, the Company invested $400,000 for a 10% limited partnership interest in Ampco Partners, Ltd. (“Ampco”), a newly formed entity, which acquired the assets and intellectual property of the Ampco Safety Tools division of Ampco Metals Incorporated of Milwaukee, Wisconsin in a Chapter 11 bankruptcy proceeding. Ampco Safety Tools, founded in 1922, is a leading manufacturer of non-sparking, non-magnetic and corrosion resistant safety tools. These tools are designed to meet Occupational Safety and Health Administration and National Fire Protection Association requirements for use in locations where flammable vapors of combustible residues are present. Safety tools are used in industrial applications, primarily in manufacturing and maintenance operations. The Company receives quarterly distributions based upon 10% of Ampco’s reported quarterly earnings before interest, taxes, depreciation and amortization expense, or EBITDA. The Company’s investment in Ampco is accounted for under the equity method. The Company recognizes its proportionate share of Ampco’s net income, as “investment income” in the consolidated statements of operations. Distributions received that exceed the Company’s 10% interest in Ampco’s net income are accounted for as return of capital and reduction in the investment in Ampco. The Company received distributions of approximately $35,000 and $24,000 for the quarters ended March 31, 2004 and 2003, respectively, and recorded approximately $24,000 and $14,000 in investment income for the quarters ended March 31, 2004 and 2003, respectively.

 

VTE, L.P.

 

On August 1, 2002, the Company formed a wholly owned subsidiary, which serves as the corporate general partner of VTE, L.P. (“VTE”), a partnership which acquired the assets (primarily software) of Venue Ticket Exchange, Inc. which was in the early stages of attempting to roll out an online, electronic ticket exchange for the purchase and sale of secondary tickets to sporting events and other entertainment venues. In connection with its formation, VTE received approximately $256,000 from the issuance of various limited partnership interests and $75,000 from the Company for general partner and limited partnership interests. Mr. Leslie, the Chairman, and Mr. Bowe, the President and CEO of Ascendant, individually, made limited partnership investments in VTE on the same terms as outside limited partnership investors. In the first and second quarters of 2003, VTE received approximately $313,500 from the issuance of additional limited partnership interests, including approximately $75,000 from the

 

4


Table of Contents

Company. The Company’s aggregate investment of $150,000 represents an ownership interest of 23.3% in VTE. VTE is accounted for as a consolidated entity in the consolidated financial statements.

 

VTE acquired the assets of Venue Ticket Exchange, Inc. for approximately $75,000 and made additional expenditures of approximately $171,000 in 2002 and 2003 for software enhancements and improvements (approximately $102,000 was capitalized and approximately $69,000 was expensed). In addition, VTE has incurred approximately $472,000 of startup, development and marketing expenses (including approximately $12,000 in the first quarter of 2004) and has approximately $1,000 in working capital remaining as of March 31, 2004.

 

VTE has generated no revenues and at year-end 2003, management evaluated, and wrote down, the carrying value of VTE’s investment in its computer software and hardware acquired. During the first quarter of 2004, all operating activities of VTE were suspended and management of the Company continues to evaluate possible business opportunities for VTE’s proprietary software including the possible sale or licensing of its software to potential third party buyers.

 

CRESA Capital Markets Group, L.P.

 

In late October 2002, the Company formed a capital markets subsidiary, CRESA Capital Markets Group, L.P., (“Capital Markets”) and entered into a licensing and co-marketing agreement with CRESA Partners LLC, a national real estate services firm. The Company owns 80% of Capital Markets through its general and limited partnership interests and has committed to fund up to $100,000 in Capital Markets. The remaining 20% of Capital Markets is owned, directly or indirectly, by three of its principals. In connection with its formation, Capital Markets received approximately $200,000 from the issuance of limited partnership interests to CRESA Partners LLC. During the third quarter of 2003, Capital Markets received additional funding of $80,000 ($64,000 from the Company and $16,000 from the other limited partners) in the form of partner loans. These loans were repaid with interest during the fourth quarter of 2003, from the proceeds of approximately $425,000 in real estate advisory services earned by Capital Markets from the purchase and sale of a commercial office building.

 

Capital Markets provides real estate financial advisory services to corporate clients on a fee basis. These services include, but are not limited to, analysis, consulting, acquisition and/or disposition of property, capital placement and acquisition, contract negotiation, and other matters related to real estate finance. Capital Markets had net service revenues of approximately $470,000 and $40,000 during the quarters ended March 31, 2004 and 2003, respectively. Since Capital Markets is still in the early development phase, its fee income can be significantly affected by a limited number of large transactions. Therefore the Company is unable to predict the level of Capital Markets’ continuing revenues. Capital Markets is accounted for as a consolidated entity in the consolidated financial statements. Mr. Leslie, the Chairman, also serves as an advisor to the Board of Directors of CRESA Partners, LLC. Capital Markets currently employs six people, including Mr. Leslie and certain of the Company’s other affiliates.

 

Fairways Equities LLC

 

During the fourth quarter of 2003, the Company entered into a participation agreement (the “Participation Agreement”) with Fairways Equities LLC (“Fairways”), an entity controlled by Jim Leslie, the Company’s Chairman, and other principals of Capital Markets, pursuant to which the Company will receive up to 20% of the profits realized by Fairways in connection with all real estate acquisitions made by Fairways. Additionally, the Company will have an opportunity, but not the obligation, to invest in the transactions undertaken by Fairways. The Company’s profit participation with the principals of Fairways is subject to modification or termination by Fairways at the end of 2005 in the event that the aggregate level of cash flow (as defined in the Participation Agreement) generated by the acquired operating entities has not reached $2 million for the twelve months ended December 31, 2005. The Company is unable to determine what real estate Fairways may acquire or the cost, type, location, or other specifics about such real estate. During December 2003, the Company advanced approximately $145,000 as a deposit related to the December 2003 Fairways transaction described herein which was returned to the Company during December 2003. During December 2003, Fairways, through a partnership with an institutional investor,

 

5


Table of Contents

acquired the stock of a company whose sole asset was a single tenant office building and entered into a long-term credit tenant lease with the former owner of the building. Based upon the terms of the current lease which expires in 2015 and the secured loans incurred by the partnership to fund the acquisition, which bear interest at LIBOR plus 1.75% to 2.25% and mature in 12 to 24 months, the Company expects to receive approximately $220,000 per year from the Company’s share of the net rental payments, after debt service, from the partnership. These proceeds will vary if the lease is modified or terminated, if the terms of the loans are modified or if there is a default by the tenant. There can be no assurances that the Company will be able to generate the required cash flow to continue in the Fairways Participation Agreement after 2005, or that Fairways will be able to acquire additional real estate assets, that the Company will choose to invest in such real estate acquisitions or that there will be profits realized by such real estate investments. The Company does not have an investment in Fairways, but rather a profits interest through its Participation Agreement. During the first quarter of 2004 the Company earned approximately $46,000 from its profit participations in Fairways’ transactions, which is included in investment income.

 

2004 INVESTMENTS

 

Dougherty’s Holdings, Inc.

 

On March 24, 2004, the Company acquired, through a newly formed, wholly owned subsidiary, Dougherty’s Holdings, Inc. (“DHI”), substantially all of the assets of Park Pharmacy Corporation (the “Park Assets”) pursuant to the Joint Plan and the Asset Purchase Agreement (the “Agreement”) entered into December 9, 2003 between Park Pharmacy and DHI. Park Pharmacy had been operating as a debtor in possession since December 2, 2002. The purchased assets include all of the cash and certain other assets of Park Pharmacy and all equity interests of the following entities (each directly or indirectly wholly-owned by Park Pharmacy): (i) Dougherty’s Pharmacy, Inc., (ii) Park Operating GP, LLC, (iii) Park LP Holdings, Inc., (iv) Park-Medicine Man GP LLC (v) Park Infusion Services, L.P., and (vi) Park-Medicine Man, L.P.

 

DHI is a provider of health care services through retail pharmacies and infusion therapy/specialty pharmacy services units. Based in Dallas, Texas, DHI operates Dougherty’s Pharmacy Inc. in Dallas, a specialty compounding pharmacy, and three specialty pharmacies in the area between Houston and the Gulf of Mexico coast under the name “Medicine Man.” Three infusion therapy/specialty pharmacy services operated under the name “Park Infusion Services” are located in Dallas, San Antonio and Houston, Texas.

 

The Company acquired the Park Assets by investing, through DHI, an aggregate of approximately $1.5 million in cash, funded out of the Company’s working capital, and the assumption by DHI of approximately $6.3 million in debt of Park Pharmacy. In addition, and pursuant to the asset purchase agreement, approximately $1.35 million (including $1.1 million due AmeriSourceBergen Drug Corporation described below) of acquired liabilities were paid at closing or through the period ending March 31, 2004.

 

In connection with the acquisition of the Park Assets, DHI entered into a new credit facility with Bank of Texas, the prior lender to Park Pharmacy Corporation. This new facility provides for three notes, aggregating approximately $5.5 million. Each note bears interest at six percent and matures in three years. Although DHI has committed to use commercially reasonable efforts to locate a replacement lender as soon as possible, DHI is obligated to make monthly payments (consisting of both interest and principal payments, as applicable) to the bank of approximately $56,000. The new credit facility is secured by substantially all of the assets of DHI, including the stock of its operating subsidiaries.

 

In connection with the acquisition of the Park Assets, DHI entered into a three year supply agreement with AmerisourceBergen Drug Corporation (“AmerisourceBergen”) pursuant to which DHI and the newly acquired indirect subsidiaries agreed to purchase prescription and over-the-counter pharmaceuticals from AmerisourceBergen through March 2007. This supply agreement will also provide DHI with pricing and payment terms that are improved from those previously provided by AmerisourceBergen to Park Pharmacy. In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic

 

6


Table of Contents

pharmaceutical products from AmerisourceBergen and agreed to minimum monthly purchases of $900,000 of all products in order to obtain new favorable pricing terms. AmerisourceBergen was a creditor of the operating non-debtor subsidiaries and, in connection with the Chapter 11 bankruptcy proceeding, AmerisourceBergen agreed to accept a cash payment of approximately $1.1 million and a promissory note in the amount of approximately $750,000 payable by DHI over a period of five years, using a 15-year amortization schedule and an interest rate of six percent with the last payment being a balloon payment of the outstanding principal and accrued but unpaid interest.

 

Both the new credit facility with the Bank of Texas and the note with AmerisourceBergen provides for prepayment discounts in the event that these loans are retired prior to maturity.

 

The accounts of DHI and its subsidiaries are included in the accompanying condensed consolidated financial statements from date of acquisition on March 24, 2004. The Company has not completed its analysis of this purchase and as such the following purchase accounting information should be considered preliminary.

 

Through March 31, 2004, the Company has incurred a total purchase price of approximately $6.8 million which includes acquisition costs of approximately $472,000 and debt assumed of approximately $6.3 million. The Company expects to incur additional purchase costs in the second quarter of 2004 associated with the evaluation of this purchase and the costs associated with its audit of Park’s historical financial statements to be included in its 8-K filing with the Securities and Exchange Commission. The acquisition will be accounted for using the purchase method of accounting. The purchase price has been preliminarily allocated as follows:

 

Net cash acquired

   $ 1,396,000

Fair value of net tangible assets acquired

     5,035,000

Intangible assets

     370,000
    

     $ 6,801,000
    

 

7


Table of Contents
3. Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Healthcare service revenue

 

Healthcare service product sales and other revenue are reported at the estimated net realizable amounts expected to be received from individuals, third-party payors, institutional healthcare providers and others. The Company recognizes revenue from the sale of pharmaceutical products and retail merchandise as transactions occur and product is delivered to the customer. Revenue from healthcare services is recognized at the time services are provided.

 

Healthcare service inventories

 

Inventories consists of healthcare service finished goods held for resale, valued at the lower of cost, using the first-in, first-out method, or market and were comprised of approximately $1.35 million in pharmaceutical products and approximately $923,000 in retail and other merchandise at March 31, 2004:

 

Accounting for Impairment of Long-Lived Assets

 

In accordance with Statement of Financial Accounting Standards No. 144 Accounting for the Impairment or Disposal of Long-Lived Assets, the Company has adopted a policy of recording an impairment loss on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amount.

 

Purchase Accounting

 

See Note 2 to the condensed consolidated financial statements.

 

Stock-Based Compensation

 

See Note 9 to the condensed consolidated financial statements.

 

4. Cash and Cash Equivalents